Senior Director, Pharma Toxicology

Bausch+Lomb Companies Inc.•USA - Remote, OR

1d•$225,000 - $300,000•Remote

About The Position

The Senior Director, Pharma Toxicology is the enterprise leader for nonclinical safety across Bausch + Lomb’s pharmaceutical, over-the-counter, and consumer portfolio. Reporting to R&D leadership, this role sets global nonclinical safety strategy, leads and develops the toxicology organization, and serves as the company’s senior scientific authority on toxicology for development programs, lifecycle management, business development, and health-authority interactions. The position partners with R&D, Regulatory, Clinical, Quality, and Commercial leadership to support portfolio decisions, accelerate development timelines, and protect patients and the business. The role oversees nonclinical safety programs from planning and execution through interpretation and communication, supporting clinical development, regulatory submissions and registrations, product launch, market support, and compliance. It also leads regulatory strategy, due diligence for business-development opportunities, organizational development, CRO and external-expert relationships, and continuous improvement of global processes and standards. The position may be based remotely in the United States.

Requirements

Ph.D. in Toxicology or a related discipline.
15 or more years of relevant pharmaceutical industry experience in nonclinical safety or toxicology.
People leadership experience, including leading managers and building or scaling teams.
Demonstrated track record of setting nonclinical strategy for multiple programs from discovery through registration and lifecycle management, including direct interaction with the FDA and/or other global health authorities.
Deep knowledge of global nonclinical regulatory requirements and guidance, such as ICH, and GLP regulations.
Experience managing departmental budgets and strategic CRO/vendor relationships.
Proven ability to influence senior leadership and communicate complex scientific risk clearly to executive and non-technical audiences.
Applicants must be authorized to work for any employer in the United States; visa sponsorship or takeover of sponsorship is not available.

Nice To Haves

Experience in ophthalmology drug development is highly desirable.
DABT certification is preferred.

Responsibilities

Define and own global nonclinical safety and toxicology strategy for pharmaceutical, over-the-counter, and consumer products, aligned with the R&D portfolio and corporate objectives.
Serve as the company’s senior toxicology subject matter expert in meetings with the FDA and other global health authorities, and lead nonclinical strategy for regulatory milestones including pre-IND, IND, end-of-phase, NDA/MAA, and post-approval activities.
Lead nonclinical due diligence for in-licensing, acquisition, and partnership opportunities, and advise senior leadership on nonclinical risks and integration requirements.
Monitor evolving regulatory guidance, scientific advances, and industry standards, including New Approach Methodologies and alternatives to animal testing; assess portfolio impacts and drive adoption where appropriate.
Build, lead, and develop a high-performing toxicology organization; set goals, manage performance, and drive succession and talent planning.
Foster scientific excellence, accountability, and collaboration; coach and mentor team members.
Establish strategic relationships with CROs and external experts; oversee vendor selection, contracting, performance, and study quality, including GLP compliance.
Oversee the design, execution, interpretation, and communication of nonclinical safety programs supporting clinical development, regulatory submissions and registrations, product launch, market support, and compliance.
Provide final scientific review and approval of nonclinical sections of regulatory submissions, safety assessments, and technical reports; ensure scientific rigor and consistency across the portfolio.
Partner with executive and cross-functional leaders, including Product Development, Clinical Development, Analytical Chemistry, Regulatory Affairs, Quality, Compliance, and Commercial, to align nonclinical plans with program and business objectives.
Direct collaboration with international company sites to address nonclinical safety requirements for country-specific submissions, registrations, and ongoing business needs.
Lead development, implementation, and continuous improvement of global departmental processes, standards, and best practices, and drive harmonization across sites.
Represent Bausch + Lomb through scientific publications, conference presentations, and industry consortia.